Trial intelligence / Profile preview

TARGET-FIRST: Short DAPT with Firehawk Stent

NCT04753749Completed

Sponsor
MicroPort
Start
Mar 2021
Primary completion
May 2025
Countries
6
01

Overview

Randomised, open-label trial in acute myocardial infarction (AMI) (2 arms), sponsored by MicroPort. Primary endpoint: Net Adverse Clinical and Cerebral Events. Started Mar 2021; status: completed.

02

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT04753749.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04753749.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call